{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:45:14Z","timestamp":1792507514427,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Our study aimed to investigate the incidence, risk factors and time to occurrence of malignancy in patients with dermatomyositis (DM) and polymyositis (PM). The electronic medical records of 1100 patients with DM and 1164 patients with PM were studied between January 2001 and May 2019. Malignancies after myositis were diagnosed in 61 (5.55%) patients with DM and 38 (3.26%) patients with PM. The cumulative incidence of malignancies in patients with DM were significantly higher than patients with PM (hazard ratio\u2009=\u20091.78, log-rank p\u2009=\u20090.004). Patients with DM had a greater risk of developing malignancy than those with PM at 40\u201359\u00a0years old (p\u2009=\u20090.01). Most malignancies occurred within 1\u00a0year after the initial diagnosis of DM (n\u2009=\u200935; 57.38%). Nasopharyngeal cancer (NPC) was the most common type of malignancy in patients with DM (22.95%), followed by lung, and breast cancers. In patients with PM, colorectal, lung and hepatic malignancies were the top three types of malignancy. The risk factors for malignancy included old age (\u2265\u200945\u00a0years old) and low serum levels of creatine phosphokinase (CPK) for patients with DM and male sex and low serum levels of CPK for patients with PM. Low serum levels of CPK in patients with myositis with malignancy represented a low degree of muscle destruction\/inflammation, which might be attributed to activation of the PD-L1 pathway by tumor cells, thus inducing T-cell dysfunction mediating immune responses in myofibers. A treatment and follow-up algorithm should explore the occurrence of malignancy in different tissues and organs and suggested annual follow-ups for at least 5.5\u00a0years to cover the 80% cumulative incidence of malignancy in patients with DM and PM.<\/jats:p>","DOI":"10.1038\/s41598-021-83729-5","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T11:04:11Z","timestamp":1614251051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan"],"prefix":"10.1038","volume":"11","author":[{"given":"Jung-Lung","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Feng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Che","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chou","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Kuo","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Shiu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ching","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing-I.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Kuang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pai-Wei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Sun","family":"Ro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"83729_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1749-6632.2009.05119.x","volume":"1184","author":"AL Mammen","year":"2010","unstructured":"Mammen, A. L. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Ann. N. Y. Acad. Sci. 1184, 134\u2013153. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05119.x (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"83729_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/mus.24566","volume":"51","author":"AR Findlay","year":"2015","unstructured":"Findlay, A. R., Goyal, N. A. & Mozaffar, T. An overview of polymyositis and dermatomyositis. Muscle Nerve 51, 638\u2013656. https:\/\/doi.org\/10.1002\/mus.24566 (2015).","journal-title":"Muscle Nerve"},{"key":"83729_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2474-13-103","volume":"13","author":"KE Smoyer-Tomic","year":"2012","unstructured":"Smoyer-Tomic, K. E., Amato, A. A. & Fernandes, A. W. Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: An administrative claims analysis. BMC Musculoskelet. Disord. 13, 103. https:\/\/doi.org\/10.1186\/1471-2474-13-103 (2012).","journal-title":"BMC Musculoskelet. Disord."},{"key":"83729_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/mus.23302","volume":"45","author":"DE Furst","year":"2012","unstructured":"Furst, D. E., Amato, A. A., Iorga, S. R., Gajria, K. & Fernandes, A. W. Epidemiology of adult idiopathic inflammatory myopathies in a US managed care plan. Muscle Nerve 45, 676\u2013683. https:\/\/doi.org\/10.1002\/mus.23302 (2012).","journal-title":"Muscle Nerve"},{"key":"83729_CR5","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/j.1365-2133.2011.10595.x","volume":"165","author":"CF Kuo","year":"2011","unstructured":"Kuo, C. F. et al. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Br. J. Dermatol. 165, 1273\u20131279. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10595.x (2011).","journal-title":"Br. J. Dermatol."},{"key":"83729_CR6","unstructured":"G, S. Polymyositis. Berl Klin Wochenschr, 20:489 (1916)."},{"key":"83729_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.7326\/0003-4819-84-1-68","volume":"84","author":"BE Barnes","year":"1976","unstructured":"Barnes, B. E. & Mawr, B. Dermatomyositis and malignancy. A review of the literature. Ann. Intern Med. 84, 68\u201376. https:\/\/doi.org\/10.7326\/0003-4819-84-1-68 (1976).","journal-title":"Ann. Intern Med."},{"key":"83729_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJM199202063260602","volume":"326","author":"B Sigurgeirsson","year":"1992","unstructured":"Sigurgeirsson, B., Lindelof, B., Edhag, O. & Allander, E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N. Engl. J. Med. 326, 363\u2013367. https:\/\/doi.org\/10.1056\/NEJM199202063260602 (1992).","journal-title":"N. Engl. J. Med."},{"key":"83729_CR9","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","volume":"134","author":"R Buchbinder","year":"2001","unstructured":"Buchbinder, R., Forbes, A., Hall, S., Dennett, X. & Giles, G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann. Intern. Med. 134, 1087\u20131095. https:\/\/doi.org\/10.7326\/0003-4819-134-12-200106190-00008 (2001).","journal-title":"Ann. Intern. Med."},{"key":"83729_CR10","doi-asserted-by":"publisher","first-page":"R70","DOI":"10.1186\/ar2987","volume":"12","author":"YJ Chen","year":"2010","unstructured":"Chen, Y. J. et al. Cancer risks of dermatomyositis and polymyositis: A nationwide cohort study in Taiwan. Arthritis Res. Ther. 12, R70. https:\/\/doi.org\/10.1186\/ar2987 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"83729_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1203475416665601","volume":"21","author":"JK Qiang","year":"2017","unstructured":"Qiang, J. K., Kim, W. B., Baibergenova, A. & Alhusayen, R. Risk of malignancy in dermatomyositis and polymyositis. J. Cutan. Med. Surg. 21, 131\u2013136. https:\/\/doi.org\/10.1177\/1203475416665601 (2017).","journal-title":"J. Cutan. Med. Surg."},{"key":"83729_CR12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00296-012-2489-y","volume":"33","author":"V Limaye","year":"2013","unstructured":"Limaye, V. et al. The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis. Rheumatol. Int. 33, 965\u2013971. https:\/\/doi.org\/10.1007\/s00296-012-2489-y (2013).","journal-title":"Rheumatol. Int."},{"key":"83729_CR13","first-page":"1300","volume":"22","author":"A Airio","year":"1995","unstructured":"Airio, A., Pukkala, E. & Isomaki, H. Elevated cancer incidence in patients with dermatomyositis: A population based study. J. Rheumatol. 22, 1300\u20131303 (1995).","journal-title":"J. Rheumatol."},{"key":"83729_CR14","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.3899\/jrheum.110320","volume":"38","author":"MW So","year":"2011","unstructured":"So, M. W., Koo, B. S., Kim, Y. G., Lee, C. K. & Yoo, B. Idiopathic inflammatory myopathy associated with malignancy: A retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis. J. Rheumatol. 38, 2432\u20132435. https:\/\/doi.org\/10.3899\/jrheum.110320 (2011).","journal-title":"J. Rheumatol."},{"key":"83729_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12016-015-8511-x","volume":"52","author":"E Tiniakou","year":"2017","unstructured":"Tiniakou, E. & Mammen, A. L. Idiopathic inflammatory myopathies and malignancy: A comprehensive review. Clin. Rev. Allergy Immunol. 52, 20\u201333. https:\/\/doi.org\/10.1007\/s12016-015-8511-x (2017).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"83729_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3899\/jrheum.140566","volume":"42","author":"Z Yang","year":"2015","unstructured":"Yang, Z., Lin, F., Qin, B., Liang, Y. & Zhong, R. Polymyositis\/dermatomyositis and malignancy risk: A metaanalysis study. J. Rheumatol. 42, 282\u2013291. https:\/\/doi.org\/10.3899\/jrheum.140566 (2015).","journal-title":"J. Rheumatol."},{"key":"83729_CR17","doi-asserted-by":"publisher","first-page":"509354","DOI":"10.1155\/2013\/509354","volume":"2013","author":"P Ungprasert","year":"2013","unstructured":"Ungprasert, P. et al. Clinical features of inflammatory myopathies and their association with malignancy: A systematic review in Asian population. ISRN Rheumatol. 2013, 509354. https:\/\/doi.org\/10.1155\/2013\/509354 (2013).","journal-title":"ISRN Rheumatol."},{"key":"83729_CR18","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.3390\/ijerph16111982","volume":"16","author":"YY Hsu","year":"2004","unstructured":"Hsu, Y. Y. et al. Health disparities of employees in Taiwan with major cancer diagnosis from 2004 to 2015: A nation- and population-based analysis. Int. J. Environ. Res. Public Health 16, 2019. https:\/\/doi.org\/10.3390\/ijerph16111982 (2004).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"83729_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med. 292, 403\u2013407. https:\/\/doi.org\/10.1056\/NEJM197502202920807 (1975).","journal-title":"N. Engl. J. Med."},{"key":"83729_CR20","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s10067-016-3296-8","volume":"35","author":"YF Fang","year":"2016","unstructured":"Fang, Y. F., Wu, Y. J., Kuo, C. F., Luo, S. F. & Yu, K. H. Malignancy in dermatomyositis and polymyositis: Analysis of 192 patients. Clin. Rheumatol. 35, 1977\u20131984. https:\/\/doi.org\/10.1007\/s10067-016-3296-8 (2016).","journal-title":"Clin. Rheumatol."},{"key":"83729_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/ene.13357","volume":"25","author":"KEN Clark","year":"2018","unstructured":"Clark, K. E. N. & Isenberg, D. A. A review of inflammatory idiopathic myopathy focusing on polymyositis. Eur. J. Neurol. 25, 13\u201323. https:\/\/doi.org\/10.1111\/ene.13357 (2018).","journal-title":"Eur. J. Neurol."},{"key":"83729_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill, C. L. et al. Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study. Lancet 357, 96\u2013100. https:\/\/doi.org\/10.1016\/S0140-6736(00)03540-6 (2001).","journal-title":"Lancet"},{"key":"83729_CR23","first-page":"615","volume":"32","author":"D Chen","year":"2014","unstructured":"Chen, D. et al. Incidence and predictive factors for malignancies with dermatomyositis: A cohort from southern China. Clin. Exp. Rheumatol. 32, 615\u2013621 (2014).","journal-title":"Clin. Exp. Rheumatol."},{"key":"83729_CR24","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.rpor.2014.02.005","volume":"19","author":"JW Teoh","year":"2014","unstructured":"Teoh, J. W., Yunus, R. M., Hassan, F., Ghazali, N. & Abidin, Z. A. Nasopharyngeal carcinoma in dermatomyositis patients: A 10-year retrospective review in Hospital Selayang, Malaysia. Rep. Pract. Oncol. Radiother. 19, 332\u2013336. https:\/\/doi.org\/10.1016\/j.rpor.2014.02.005 (2014).","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"83729_CR25","first-page":"219","volume":"29","author":"P Ang","year":"2000","unstructured":"Ang, P., Sugeng, M. W. & Chua, S. H. Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: A 3-year retrospective review of their clinical characteristics and association with malignancy. Ann. Acad. Med. Singap. 29, 219\u2013223 (2000).","journal-title":"Ann. Acad. Med. Singap."},{"key":"83729_CR26","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.3892\/ol.2018.9409","volume":"16","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Characteristics and predictors of malignancy in dermatomyositis: Analysis of 239 patients from northern China. Oncol. Lett. 16, 5960\u20135968. https:\/\/doi.org\/10.3892\/ol.2018.9409 (2018).","journal-title":"Oncol. Lett."},{"key":"83729_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s10165-010-0362-y","volume":"21","author":"K Azuma","year":"2011","unstructured":"Azuma, K. et al. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis. Mod. Rheumatol. 21, 178\u2013183. https:\/\/doi.org\/10.1007\/s10165-010-0362-y (2011).","journal-title":"Mod. Rheumatol."},{"key":"83729_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5582\/ddt.2017.01030","volume":"11","author":"N Roy Chattopadhyay","year":"2017","unstructured":"Roy Chattopadhyay, N., Das, P., Chatterjee, K. & Choudhuri, T. Higher incidence of nasopharyngeal carcinoma in some regions in the world confers for interplay between genetic factors and external stimuli. Drug Discov. Ther. 11, 170\u2013180. https:\/\/doi.org\/10.5582\/ddt.2017.01030 (2017).","journal-title":"Drug Discov. Ther."},{"key":"83729_CR29","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","volume":"365","author":"WI Wei","year":"2005","unstructured":"Wei, W. I. & Sham, J. S. Nasopharyngeal carcinoma. Lancet 365, 2041\u20132054. https:\/\/doi.org\/10.1016\/S0140-6736(05)66698-6 (2005).","journal-title":"Lancet"},{"key":"83729_CR30","first-page":"1046","volume":"6","author":"K Shotelersuk","year":"2000","unstructured":"Shotelersuk, K. et al. Epstein\u2013Barr virus DNA in serum\/plasma as a tumor marker for nasopharyngeal cancer. Clin. Cancer Res. 6, 1046\u20131051 (2000).","journal-title":"Clin. Cancer Res."},{"key":"83729_CR31","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1056\/NEJMoa032260","volume":"350","author":"JC Lin","year":"2004","unstructured":"Lin, J. C. et al. Quantification of plasma Epstein\u2013Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N. Engl. J. Med. 350, 2461\u20132470. https:\/\/doi.org\/10.1056\/NEJMoa032260 (2004).","journal-title":"N. Engl. J. Med."},{"key":"83729_CR32","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3109\/00016489.2014.913312","volume":"134","author":"PY Huang","year":"2014","unstructured":"Huang, P. Y. et al. Paired study of 172 cases of nasopharyngeal carcinoma with or without dermatomyositis. Acta Otolaryngol. 134, 824\u2013830. https:\/\/doi.org\/10.3109\/00016489.2014.913312 (2014).","journal-title":"Acta Otolaryngol."},{"key":"83729_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1574-6968.1990.tb03524.x","volume":"2","author":"MC Yu","year":"1990","unstructured":"Yu, M. C. Diet and nasopharyngeal carcinoma. FEMS Microbiol. Immunol. 2, 235\u2013242. https:\/\/doi.org\/10.1111\/j.1574-6968.1990.tb03524.x (1990).","journal-title":"FEMS Microbiol. Immunol."},{"key":"83729_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/nu8030112","volume":"8","author":"C Wang","year":"2016","unstructured":"Wang, C. et al. Diet Quality scores and risk of nasopharyngeal carcinoma in Chinese adults: A case\u2013control study. Nutrients 8, 112. https:\/\/doi.org\/10.3390\/nu8030112 (2016).","journal-title":"Nutrients"},{"key":"83729_CR35","first-page":"1461","volume":"138","author":"TC Wu","year":"1991","unstructured":"Wu, T. C. et al. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein\u2013Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am. J. Pathol. 138, 1461\u20131469 (1991).","journal-title":"Am. J. Pathol."},{"key":"83729_CR36","first-page":"1355","volume":"146","author":"R Pathmanathan","year":"1995","unstructured":"Pathmanathan, R. et al. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein\u2013Barr virus-infected neoplasia. Am. J. Pathol. 146, 1355\u20131367 (1995).","journal-title":"Am. J. Pathol."},{"key":"83729_CR37","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.7754\/clin.lab.2015.151122","volume":"62","author":"Y Chen","year":"2016","unstructured":"Chen, Y. et al. Diagnostic value of serum Epstein\u2013Barr virus capsid antigen-IgA for nasopharyngeal carcinoma: A meta-analysis based on 21 studies. Clin. Lab. 62, 1155\u20131166. https:\/\/doi.org\/10.7754\/clin.lab.2015.151122 (2016).","journal-title":"Clin. Lab."},{"key":"83729_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bbacli.2014.10.003","volume":"2","author":"FP Zhao","year":"2014","unstructured":"Zhao, F. P. et al. Positivity of both plasma Epstein\u2013Barr virus DNA and serum Epstein\u2013Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma. BBA Clin. 2, 88\u201393. https:\/\/doi.org\/10.1016\/j.bbacli.2014.10.003 (2014).","journal-title":"BBA Clin."},{"key":"83729_CR39","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jcv.2010.08.015","volume":"49","author":"DY Chen","year":"2010","unstructured":"Chen, D. Y. et al. Polymyositis\/dermatomyositis and nasopharyngeal carcinoma: The Epstein\u2013Barr virus connection?. J. Clin. Virol. 49, 290\u2013295. https:\/\/doi.org\/10.1016\/j.jcv.2010.08.015 (2010).","journal-title":"J. Clin. Virol."},{"key":"83729_CR40","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1196\/annals.1422.059","volume":"1108","author":"O Barzilai","year":"2007","unstructured":"Barzilai, O. et al. Epstein\u2013Barr virus and cytomegalovirus in autoimmune diseases: Are they truly notorious? A preliminary report. Ann. N. Y. Acad. Sci. 1108, 567\u2013577. https:\/\/doi.org\/10.1196\/annals.1422.059 (2007).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"83729_CR41","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.nmd.2019.09.014","volume":"29","author":"A Selva-O'Callaghan","year":"2019","unstructured":"Selva-O\u2019Callaghan, A. et al. Malignancy and myositis, from molecular mimicry to tumor infiltrating lymphocytes. Neuromuscul. Disord. 29, 819\u2013825. https:\/\/doi.org\/10.1016\/j.nmd.2019.09.014 (2019).","journal-title":"Neuromuscul. Disord."},{"key":"83729_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.clim.2014.04.010","volume":"153","author":"A Pedoeem","year":"2014","unstructured":"Pedoeem, A., Azoulay-Alfaguter, I., Strazza, M., Silverman, G. J. & Mor, A. Programmed death-1 pathway in cancer and autoimmunity. Clin. Immunol. 153, 145\u2013152. https:\/\/doi.org\/10.1016\/j.clim.2014.04.010 (2014).","journal-title":"Clin. Immunol."},{"key":"83729_CR43","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3899\/jrheum.170544","volume":"45","author":"H Chen","year":"2018","unstructured":"Chen, H. et al. Increased levels of soluble programmed death ligand 1 associate with malignancy in patients with dermatomyositis. J. Rheumatol. 45, 835\u2013840. https:\/\/doi.org\/10.3899\/jrheum.170544 (2018).","journal-title":"J. Rheumatol."},{"key":"83729_CR44","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1097\/COC.0000000000000449","volume":"41","author":"N Larbcharoensub","year":"2018","unstructured":"Larbcharoensub, N. et al. Characterization of PD-L1 and PD-1 expression and CD8+ tumor-infiltrating lymphocyte in Epstein\u2013Barr virus-associated nasopharyngeal carcinoma. Am. J. Clin. Oncol. 41, 1204\u20131210. https:\/\/doi.org\/10.1097\/COC.0000000000000449 (2018).","journal-title":"Am. J. Clin. Oncol."},{"key":"83729_CR45","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1212\/NXI.0000000000000558","volume":"6","author":"S Knauss","year":"2019","unstructured":"Knauss, S. et al. PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited. Neurol. Neuroimmunol. Neuroinflamm. 6, e558. https:\/\/doi.org\/10.1212\/NXI.0000000000000558 (2019).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"83729_CR46","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","volume":"144","author":"YJ Chen","year":"2001","unstructured":"Chen, Y. J., Wu, C. Y. & Shen, J. L. Predicting factors of malignancy in dermatomyositis and polymyositis: A case\u2013control study. Br. J. Dermatol. 144, 825\u2013831. https:\/\/doi.org\/10.1046\/j.1365-2133.2001.04140.x (2001).","journal-title":"Br. J. Dermatol."},{"key":"83729_CR47","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3349\/ymj.2006.47.4.519","volume":"47","author":"SW Lee","year":"2006","unstructured":"Lee, S. W., Jung, S. Y., Park, M. C., Park, Y. B. & Lee, S. K. Malignancies in Korean patients with inflammatory myopathy. Yonsei Med. J. 47, 519\u2013523. https:\/\/doi.org\/10.3349\/ymj.2006.47.4.519 (2006).","journal-title":"Yonsei Med. J."},{"key":"83729_CR48","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s00296-019-04428-z","volume":"39","author":"K Motomura","year":"2019","unstructured":"Motomura, K., Yamashita, H., Yamada, S., Takahashi, Y. & Kaneko, H. Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: A 25-year retrospective study. Rheumatol. Int. 39, 1733\u20131739. https:\/\/doi.org\/10.1007\/s00296-019-04428-z (2019).","journal-title":"Rheumatol. Int."},{"key":"83729_CR49","first-page":"438","volume":"35","author":"C Andras","year":"2008","unstructured":"Andras, C. et al. Dermatomyositis and polymyositis associated with malignancy: A 21-year retrospective study. J. Rheumatol. 35, 438\u2013444 (2008).","journal-title":"J. Rheumatol."},{"key":"83729_CR50","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1046\/j.1365-4362.2002.01648.x","volume":"41","author":"N Wakata","year":"2002","unstructured":"Wakata, N., Kurihara, T., Saito, E. & Kinoshita, M. Polymyositis and dermatomyositis associated with malignancy: A 30-year retrospective study. Int. J. Dermatol. 41, 729\u2013734. https:\/\/doi.org\/10.1046\/j.1365-4362.2002.01648.x (2002).","journal-title":"Int. J. Dermatol."},{"key":"83729_CR51","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s10067-011-1840-0","volume":"30","author":"KH Yu","year":"2011","unstructured":"Yu, K. H. et al. Survival analysis of patients with dermatomyositis and polymyositis: Analysis of 192 Chinese cases. Clin. Rheumatol. 30, 1595\u20131601. https:\/\/doi.org\/10.1007\/s10067-011-1840-0 (2011).","journal-title":"Clin. Rheumatol."},{"key":"83729_CR52","doi-asserted-by":"publisher","first-page":"205031211878189","DOI":"10.1177\/2050312118781895","volume":"6","author":"CH Lim","year":"2018","unstructured":"Lim, C. H. et al. The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis\/polymyositis patients: A retrospective study. SAGE Open Med. 6, 2050312118781895. https:\/\/doi.org\/10.1177\/2050312118781895 (2018).","journal-title":"SAGE Open Med."},{"key":"83729_CR53","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/25785826.2018.1531188","volume":"41","author":"R Nakashima","year":"2018","unstructured":"Nakashima, R. Clinical significance of myositis-specific autoantibodies. Immunol. Med. 41, 103\u2013112. https:\/\/doi.org\/10.1080\/25785826.2018.1531188 (2018).","journal-title":"Immunol. Med."},{"key":"83729_CR54","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s10067-019-04503-7","volume":"38","author":"S Li","year":"2019","unstructured":"Li, S. et al. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies. Clin. Rheumatol. 38, 2171\u20132179. https:\/\/doi.org\/10.1007\/s10067-019-04503-7 (2019).","journal-title":"Clin. Rheumatol."},{"key":"83729_CR55","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/BOR.0000000000000535","volume":"30","author":"A Selva-O'Callaghan","year":"2018","unstructured":"Selva-O\u2019Callaghan, A., Martinez-Gomez, X., Trallero-Araguas, E. & Pinal-Fernandez, I. The diagnostic work-up of cancer-associated myositis. Curr. Opin. Rheumatol. 30, 630\u2013636. https:\/\/doi.org\/10.1097\/BOR.0000000000000535 (2018).","journal-title":"Curr. Opin. Rheumatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83729-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83729-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83729-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T04:07:12Z","timestamp":1670040432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83729-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83729"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83729-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"assertion":[{"value":"21 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4545"}}